zanubrutinib Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (2)

Phase 1/2 (1)
Phase 2 (1)

Interventional (2)

BeiGene (1)
Institute of Hematology & Blood Diseases Hospital (1)

No (2)

No (2)

Adult (18+) (2)

I am/have/had

I am/have/hadindolent lymphoma

I am/have/hadcold agglutinin

I am/have/hadtreatment regimen

I am/have/hadrenal cell carcinoma

I am/have/hadmicrosatellite instability high

I am/have/hadlarge b-cell lymphoma

I am/have/hadsmall cell lung cancer

I am/have/hadtriple-negative breast cancer

I am/have/hadsquamous cell carcinoma

I am/have/hadsystemic therapy

I am/have/hadcancer of the ovary

I am/have/hadMRI

I am/have/hadcryoglobulinemia

I am/have/hadcancer

I am/have/hadliver cancer

I am/have/hadovarian cancer

I am/have/hadesophageal cancer

I am/have/haddiffuse large b-cell lymphoma

I am/have/hadmsi-h

I am/have/hadnon-small cell lung cancer

added new label for I am/have/had

more

I am looking for

I am looking forfludarabine

I am looking fortislelizumab

I am looking forcyclophosphamide

I am looking forchlorambucil

I am looking formelanoma

I am looking fordexamethasone

I am looking forixazomib

I am looking forzanubrutinib

added new label for I am looking for

more

Advanced Filters

Loading...

Found 2 clinical trials

We call this “infoimagery”. It is unique to every trial and is generated based on a trials specific data eg. therapeutic area, study type, phase etc. and the centerwatch system associates the information to a matching set of related symbols and icons.

What's this?

Phase 2
For Seniors
For adults
Recruiting in 10s
Interventional Study
all
Oncology
Recruiting

Zanubrutinib Ixazomib and Dexamethasone in Patients With Treatment Naive Waldenstrom's Macroglobulinemia

We propose this combination will improve the deep remission (VGPR) compared to single Zanubrutinib or IRD regimen and can be a time-limited regimen which will reduce the life-time therapy and benefit the patients.

fludarabine

indolent lymphoma

amyloidosis

cold agglutinin

treatment regimen

0 views
19 Feb, 2024

Phase 1
For Seniors
For adults
Recruiting in 100s
Interventional Study
all
Family Medicine
Recruiting

Brief Title: Study of BGB-10188 as Monotherapy and in Combination With Zanubrutinib and Tislelizumab

The purpose of this study is to determine the maximum tolerated dose (MTD), recommended Phase 2 dose(RP2D),safety & tolerability of BGB-10188: as monotherapy in participants with mature B-cell malignancies; oin combination with zanubrutinib in participants with relapse/refractory follicular lymphoma (R/R FL), mantle cell lymphoma (MCL) or diffuse large B-cell lymphoma …

renal cell carcinoma

microsatellite instability high

large b-cell lymphoma

small cell lung cancer

triple-negative breast cancer

0 views
19 Feb, 2024

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2025 All rights reserved.